Skip to content
← Back to this collection

PUBLICATIONS · 38471049

European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2024 Jun 1
First author
Mahon FX

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Mahon FX
      type
      Author
    2. name
      Pfirrmann M
      type
      Author
    3. name
      Dulucq S
      type
      Author
    4. name
      Hochhaus A
      type
      Author
    5. name
      Panayiotidis P
      type
      Author
    6. name
      Almeida A
      type
      Author
    7. name
      Mayer J
      type
      Author
    8. name
      Hjorth-Hansen H
      type
      Author
    9. name
      Janssen JJWM
      type
      Author
    10. name
      Mustjoki S
      type
      Author
    11. name
      Martinez-Lopez J
      type
      Author
    12. name
      Vestergaard H
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Mahon FX
      type
      Author
    2. name
      Pfirrmann M
      type
      Author
    3. name
      Dulucq S
      type
      Author
    4. name
      Hochhaus A
      type
      Author
    5. name
      Panayiotidis P
      type
      Author
    6. name
      Almeida A
      type
      Author
    7. name
      Mayer J
      type
      Author
    8. name
      Hjorth-Hansen H
      type
      Author
    9. name
      Janssen JJWM
      type
      Author
    10. name
      Mustjoki S
      type
      Author
    11. name
      Martinez-Lopez J
      type
      Author
    12. name
      Vestergaard H
      type
      Author
    bibliography ids
    1. nci-bib-a4c3cf91f8348df2d5e20bba
    book metadata
    content sha256
    9c0a307e6cebcd2cef39219aaeac2b343e22b63eb475993922e787f2244807aa
    document type
    citation
    dois
    1. 10.1200/JCO.23.01647
    electronic publication date
    display
    2024 Mar 12
    precision
    day
    year
    2024
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:38471049
    immutable id
    pubmed:38471049@9c0a307e6cebcd2cef39219aaeac2b343e22b63eb475993922e787f2244807aa
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    16
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    1875-1880
    volume
    42
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      38471049
      provenance
      batch id
      6d213eecf21b6b7867cb
      provider
      NCBI PubMed ESummary
      record sha256
      df539383c61d2bc15dc5a3867da6c2dff4f257cfb05e8930b2f52201e90843ae
      response sha256
      684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
      retrieved at
      2026-09-09T23:48:19.049083+00:00
      publication date
      display
      2024 Jun 1
      precision
      day
      year
      2024
      publication types
      1. Journal Article
      2. Multicenter Study
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/38471049/
      title
      European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission.

      Preserved source evidence · Not medical advice